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Abstract 
Regulated apoB degradation i  HepG2 cells occurs in the endoplasmic reticulum (ER), is catalyzed by an N-acetylleucylleucyl- 
norleucinal (ALLN)-sensitive proteinase, and generates a specific 70 kDa fragment (Du, E. et al. (1994) J. Biol. Chem. 269, 9166-9175). 
In the present report, we have characterized the 70 kDa fragment by immunoprecipitation of permeabilized HepG2 cells with a battery of 
monoclonal antibodies against various sites on the apoB molecule. N-Terminal monoclonal antibodies (1D1 and 2D8) were capable of 
binding to the 70 kDa fragment :suggesting that this polypeptide is an N-terminal fragment of the intact apoB. Subcellular fractionation of 
permeabilized cells and carbonate xtraction resulted in the detection of the 70 kDa fragment in the ER lumen. Endoglycosidase H 
treatment confirmed that the fragment is N-linked glycosylated. We hypothesize that the ALLN-sensitive proteinase which may be located 
on the luminal side of the ER membrane, catalyzes an initial cleavage of apoB near the N-terminus generating a 70 kDa fragment, which 
is then released into the ER lumen. 
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A significant proportion of newly-synthesized apolipo- 
protein B (apoB) is rapidly degraded in rat hepatocytes 
[1-3] and HepG2 cells [4-7]. ApoB degradation occurs 
early in the endoplasmic reticulum or a pre-Golgi compart- 
ment [1,4,5,7]. Mistranslocated apoB chains in the ER 
membrane as well as a fraction of the luminal apoB may 
be sorted to the degradation pathway [8-10]. Studies in 
permeabilized HepG2 cells in our laboratory [7] have 
shown that apoB degradation occurs in the ER by a pH- 
and temperature-dependent process and is catalyzed by an 
N-acetylleucylleucylnorleucinal (ALLN)-sensitive, cal- 
cium-insensitive proteinase. ApoB degradation i  perme- 
abilized HepG2 cells generates pecific proteolytic frag- 
ments including an abundant 70 kDa fragment [7]. Davis 
and coworkers [11] recently reported the detection of two 
85 kDa and 69 kDa fragments following the degradation of 
apoB in intact HepG2 cells and apoB53-transfected Chi- 
Abbreviations: ALLN, N-acetylleucylleucylnorleucinal; APOB,apo- 
lipoprotein B100; ot-MEM, o~ modification fEagle's minimum essential 
medium; Endo H, endoglycosidase H; ER, endoplasmic reticulum, SDS- 
PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
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nese hamster ovary cells. The 69 kDa fragment reported by 
these investigators appears to be similar to the 70 kDa 
fragment detected in our permeabilized HepG2 cells. In the 
present report, we have further characterized the 70 kDa 
fragment and have shown that it is an N-terminal fragment 
of the apoB molecule as it is selectively recognized by 
N-terminal monoclonal antibodies. Subcellular fractiona- 
tion of HepG2 membranes has also shown that the frag- 
ment is found in the lumen of the ER, suggesting that the 
ALLN-sensitive degradation of apoB results in the release 
of a 70 kDa fragment into the ER lumen. 
HepG2 cells were maintained in an alpha modification 
of Eagle's minimal essential medium (a-MEM) containing 
10% fetal calf serum [12]. Cells (1 • 10  4 cells) were grown 
in 35 mm dishes at 37°C, 5% CO 2 in complete medium 
(ot-MEM, 10% fetal bovine serum) until about 75-85% 
confluency at which time they were used for the degrada- 
tion experiments. 
ApoB degradation in permeabilized HepG2 cells was 
assayed as follows. HepG2 cells were pulse-chased and 
were permeabilized as described previously [7] with minor 
modifications. Briefly, cells were incubated with 40-50 
/xCi/ml of [35S]protein labeling mixture for 20 min, 
washed in MEM three times, and chased in MEM contain- 
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ing 5 mM L-methionine and 1 mM L-cysteine for 10 min. 
After extensive washing, the cells were incubated in cyto- 
skeletal (CSK) buffer [7] containing 50 /xg/ml of digi- 
tonin for 10 min. Digitonized cells were washed and were 
immediately used for the degradation studies. After incuba- 
tion for different periods of time, permeabilized cells were 
solubilized in s01ubilization buffer (PBS containing 1% 
NP40, 1% deoxycholate, 5 mM EDTA, 1 mM EGTA, 2 
mM PMSF, 0.1 mM leupeptin, 2 /xg/ml ALLN). Cell 
extracts were obtained by centrifugation and were sub- 
jected to immunoprecipitation. 
Permeabilized cells were also fractionated to isolate a 
microsomal fraction and to perform sodium carbonate 
treatment to release the luminal contents. Permeabilized 
cells that had been incubated in cytoskeletal buffer for 2 h 
were homogenized in 0.25 M sucrose, 10 mM Tris-HC1 
(pH 7.4), using a dounce homogenizer. The homogenate 
was first centrifugated at 10000 × g for 30 min at 4°C. 
The supernatant was then recentrifuged at37 000 rpm for 
60 min in a SW41 rotor, to pellet the microsomes. A
portion of the microsomal fraction was treated with sodium 
carbonate pH 11 [13]. The luminal fraction released by 
carbonate buffer was separated by pelleting the mem- 
branes, and was then subjected to immunoprecipitation. 
ApoB was immunoprecipitated with a monospecific 
antibody as described [7]. Monoclonal antibodies (a gift 
from Drs. Ross Milne and Yves Marcel, Ottawa Heart 
Institute) were first bound to Affi-gel beads (Affi-gel 10, 
Bio-Rad) and then used in immunoprecipitation experi- 
ments. Briefly, samples were incubated with Affi-gel- 
monoclonal antibody beads overnight at 4°C. After this 
incubation, agarose beads were separated by centrifugation 
and were washed four times with immunoprecipitation 
wash buffer (PBS containing 1% NP40, 1% deoxycholate, 
5 mM EDTA, 0.1% SDS). Finally, the immunoprecipitates 
were prepared for SDS-PAGE by suspending and boiling 
in electrophoresis sample buffer. SDS-PAGE was per- 
formed according to Laemmli [14]. Gels were composed of 
5% (w/v) stacking and 6% (w/v) resolving gels. Elec- 
trophoresis was at 66 V for 16 h. The gels were fixed, 
stained and were fluorographed byincubating inEnhance TM 
or Enlightening TM (Dupont). The gels were dried, and 
exposed to Kodak X-Omat AR5 or Dupont autoradio- 
graphic film at -80°C. 
We used permeabilized HepG2 cells to further investi- 
gate the nature of the 70 kDa apoB fragment which is the 
most abundant fragment generated upon degradation of the 
intact 550 kDa apoB molecule [7]. Further characterization 
of this fragment was deemed to be important for a better 
understanding of the apoB degradation pathway. We had 
previously shown that the 70 kDa fragment is generated by 
an ALLN-sensitive process and was immunoprecipitable 
by a monospecific polyclonal antibody [7]. In the present 
study, a set of monoclonal antibodies with known speci- 
ficity were used to probe permeabilized cell extracts. In 
this experiment, HepG2 cells were first pulsed with 
[35S]methionine, chased briefly, and were permeabilized 
with digitonin. The 70 kDa fragment is normally detected 
in permeabilized cells after a 2 h incubation i  cytoskeletal 
buffer [7]. Permeabilized cells were solubilized and then 
challenged with a polyclonal antibody and a set of mono- 
clonal antibodies including 1D1, 2D8, 4G3, So16, and 
So116. The epitopes assigned for these monclonals are 1D1 
(474-539), 2D8 (1438-1480), 4G3 (2980-3084), So16 
(2488-2543), and So116 (4027-4081) [15]. Fig. 1 shows 
the SDS-PAGE and fluorographic analysis of the immuno- 
precipitable apoB from 2 h-incubated permeabilized HepG2 
cells. As expected, the 70 kDa fragment was selected by 
the polyclonal antibody (lanes 1 and 2). Among the mono- 
clonal antibodies tested, the 70 kDa fragment was selected 
by the N-terminal monoclonals, 1D1 (lanes 3 and 4) and 
2D8 (lanes 5 and 6) antibodies. The other monoclonals 
including 4G3, So16, and So116 did not bind to the 70 kDa 
fragment (lanes 7-12) but did bind to the intact apoB and 
the 335 kDa fragment (data not shown). The data suggest 
that the 70 kDa fragment is derived from the N-terminus 
of the apoB molecule. It is not yet known whether the 
N-terminus of the 70 kDa fragment is homologous to the 
N-terminus of the intact apoB polypeptide. The 70 kDa 
fragment may be generated by an ALLN-sensitive pro- 
teinase ither from a single cleavage at the C-terminal end 
of the fragment, or by cleavage at both the N-terminus and 
the C-terminus of the fragment. We are currently attempt- 
ing to sequence the N-terminus of the 70 kDa fragment to 
determine whether it shares the N-terminus of the intact 
apoB polypeptide, in which case cleavage at a single site 
could explain the generation of this fragment. 
We also investigated whether the 70 kDa fragment is 
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Fig. 1. The 70 kDa fragment is N-terminal in nature. HepG2 cells were pulsed for 20 rain with [35S]methionine, chased for 10 rain, and permeabilized with 
digitonin. Permeabilized cells were incubated in cytoskeletal buffer for 2 h and were then solubilized. ApoB was immunoprecipitated with a monospecific 
polyclonal antibody and a battery of monoclonal antibodies including 1D1, 2D8, 4G3, Sol6, and So116. Immunoprecipitates were analyzed with 
SDS-PAGE and fluorography. The fluorograph shows the 70 kDa apoB fragment immunoprecipitated with various antibodies. 
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Fig. 2. The 70 kDa fragment is N-linked glycosylated. HepG2 cells were 
pulsed, chased, and permeabilized a,;in Fig. 1. Permeabilized cells were 
incubated in cytoskeletal buffer for 2 h and were then solubilized. ApoB 
was immunoprecipitated with a monospecific polyclonal antibody. The 
immunoprecipitates were treated with Endo H overnight at 37°C, and 
were analyzed with SDS-PAGE and fluorography. The fluorograph shows 
the intact apoB and its 70 kDa apoB fragment immunoprecipitated from 
permeabilized cells at time 0 and after 2 h incubation in CSK buffer. Note 
that both the intact apoB and its fragment migrate faster after treatment 
with Endo H. 
N-linked glycosylated by irnmunoprecipitating permeabi- 
lized cells and treating the immunoprecipitate with endo- 
glycosidase H (Fig. 2). Endo H treatment resulted in a shift 
in the electrophoretic migration of the 70 kDa fragment, 
confirming that it contains N-linked oligosaccharides. The 
data suggest hat the 70 kDa fragment is generated only 
after the N-terminus of the apoB molecule has been N-lin- 
ked glycosylated. It also suggests that this fragment is 
exposed to the lumen of the ER where the enzymes 
necessary for N-linked glycosylation reside. 
Subcellular fractionation of permeabilized HepG2 cells 
was also performed to investigate whether the 70 kDa 
fragment is associated with the lumen of the ER. Perme- 
abilized cells prepared as in Fig. 1 were solubilized and 
then fractionated by differential centrifugation. An ER 
fraction was isolated and its purity was checked by 
NADH-cytochrome c reductase specific activity measure- 
ment. An aliquot of the ER fraction was probed with a 
polyclonal apoB antibody. A second aliquot was extracted 
by sodium carbonate buffer pH 11 [13] to remove the 
luminal contents which were separated from stripped mem- 
branes by a second centrifugation step. As shown in Fig. 3, 
the 70 kDa fragment which was detectable in 2 h-in- 
cubated permeabilized cells (lane 1), was also recovered 
from the total ER fraction (lane 2) as well as the luminal 
fraction of the ER (lane 4). A small amount of the 
fragment was found in the membranes treated with sodium 
carbonate (lane 3). These observations suggest hat the 70 
kDa fragment is at least partially released into the lumen 
of the ER upon the degradation of the intact apoB by an 
ALLN-sensitive proteinase. The data are compatible with 
the view that the N-terminus of the apoB as it emerges 
from the ER membrane is exposed to the lumen of the ER, 
and is cleaved by a site-specific proteinase which releases 
a 70 kDa fragment into the ER lumen. A recent report 
from Davis and coworkers [11] has also shown the detec- 
tion of a 69 kDa fragment in the ER lumen of intact 
HepG2 cells. These investigators also reported a 85 kDa 
fragment which was secreted from the cells but was not 
normally detected in the ER fraction of intact cells [11]. It 
was detected intracellularly only when the cells were 
pretreated with ALLN [11]. This observation suggests that 
under control conditions, the major degradation product 
which accumulates in the ER is a 69-70 kDa fragment. 
In conclusion, the ALLN-sensitive intraceUular degra- 
dation of apoB in the ER generates a specific fragment 
which is N-terminal in nature and is N-linked glycosylated. 
This specific cleavage may occur during apoB transloca- 
tion into the ER and appears to result in the release of the 
70 kDa fragment (as well as possibly other fragments) into 
the ER lumen. The data suggest hat the ALLN-sensitive 
proteinase responsible for the generation of the 70 kDa 
fragment [7] may reside in the luminal side of the ER 
membrane. 
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Fig. 3. The 70 kDa fragment is found associated with the lumen of the 
ER. HepG2 cells were pulsed, chased, and permeabilized as in Fig. I. 
Permeabilized cells were incubated in cytoskeletal buffer for 2 h and 
were then used to isolate a total microsomal preparation (see Methods). A
portion of the microsomal fraction was treated with sodium carbonate 
(pH I i )  [13]. The luminal fraction was then subjected to immunoprecip- 
itation, SDS-PAGE, and fluorography. The fluorograph shows the 70 kDa 
fragment immunoprecipitated from permeabilized cells (lane 1), the total 
ER fraction (lane 2), the microsomal membranes treated with carbonate 
buffer (lane 3), and the luminal corttents of the ER (lane 4). 
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